Three ALS Biotypes

Researchers used a machine learning model to group people with amyotrophic lateral sclerosis (ALS) into three biotypes. Each biotype points to a different treatment path: protect neurons and synapses; boost neuron–glia collaboration and regeneration; or support late-stage degeneration. If confirmed, this could guide smarter trials and personalized therapies, offering real hope to people with ALS.